These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399 [TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? Moore KN; Reid MS; Fong DN; Myers TK; Landrum LM; Moxley KM; Walker JL; McMeekin DS; Mannel RS Gynecol Oncol; 2008 Aug; 110(2):133-9. PubMed ID: 18495221 [TBL] [Abstract][Full Text] [Related]
10. Advances in the management of epithelial ovarian cancer. Berkenblit A; Cannistra SA J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease. Hou JY; Kelly MG; Yu H; McAlpine JN; Azodi M; Rutherford TJ; Schwartz PE Gynecol Oncol; 2007 Apr; 105(1):211-7. PubMed ID: 17239941 [TBL] [Abstract][Full Text] [Related]
12. Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer? Aletti GD; Long HJ; Podratz KC; Cliby WA Gynecol Oncol; 2007 Jan; 104(1):212-6. PubMed ID: 17023033 [TBL] [Abstract][Full Text] [Related]
13. Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? Pacelli F; Bossola M; Rosa F; Tortorelli AP; Papa V; Doglietto GB Clin Nutr; 2008 Jun; 27(3):398-407. PubMed ID: 18436350 [TBL] [Abstract][Full Text] [Related]
14. Steroids and poor nutrition are associated with infectious wound complications in children undergoing first stage procedures for ulcerative colitis. Markel TA; Lou DC; Pfefferkorn M; Scherer LR; West K; Rouse T; Engum S; Ladd A; Rescorla FJ; Billmire DF Surgery; 2008 Oct; 144(4):540-5; discussion 545-7. PubMed ID: 18847637 [TBL] [Abstract][Full Text] [Related]
15. Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer. Paulsen T; Kaern J; Kjaerheim K; Haldorsen T; Tropé C Gynecol Oncol; 2006 Sep; 102(3):447-52. PubMed ID: 16516277 [TBL] [Abstract][Full Text] [Related]
16. Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy. Estes JM; Leath CA; Straughn JM; Rocconi RP; Kirby TO; Huh WK; Barnes MN J Am Coll Surg; 2006 Oct; 203(4):527-32. PubMed ID: 17000397 [TBL] [Abstract][Full Text] [Related]
17. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
18. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Ryu KS; Kim JH; Ko HS; Kim JW; Ahn WS; Park YG; Kim SJ; Lee JM Gynecol Oncol; 2004 Aug; 94(2):325-32. PubMed ID: 15297169 [TBL] [Abstract][Full Text] [Related]
19. Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Bristow RE; Chi DS Gynecol Oncol; 2006 Dec; 103(3):1070-6. PubMed ID: 16875720 [TBL] [Abstract][Full Text] [Related]
20. Risk of venous access device wound complications in patients undergoing paclitaxel chemotherapy for gynecologic malignancies. Boulay RM; Olt GJ; Podczaski ES Gynecol Oncol; 1998 Aug; 70(2):259-62. PubMed ID: 9740701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]